67 related articles for article (PubMed ID: 9551400)
1. Anti-GBM glomerulonephritis in mice lacking nitric oxide synthase type 2.
Cattell V; Cook HT; Ebrahim H; Waddington SN; Wei XQ; Assmann KJ; Liew FY
Kidney Int; 1998 Apr; 53(4):932-6. PubMed ID: 9551400
[TBL] [Abstract][Full Text] [Related]
2. Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.
Heeringa P; van Goor H; Itoh-Lindstrom Y; Maeda N; Falk RJ; Assmann KJ; Kallenberg CG; Jennette JC
Am J Pathol; 2000 Mar; 156(3):879-88. PubMed ID: 10702405
[TBL] [Abstract][Full Text] [Related]
3. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis.
Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H
Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728
[TBL] [Abstract][Full Text] [Related]
4. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
5. Predominant role of FcgammaRIII in the induction of accelerated nephrotoxic glomerulonephritis.
Fujii T; Hamano Y; Ueda S; Akikusa B; Yamasaki S; Ogawa M; Saisho H; Verbeek JS; Taki S; Saito T
Kidney Int; 2003 Oct; 64(4):1406-16. PubMed ID: 12969160
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase-2 down-regulates surfactant protein-B expression and enhances endotoxin-induced lung injury in mice.
Baron RM; Carvajal IM; Fredenburgh LE; Liu X; Porrata Y; Cullivan ML; Haley KJ; Sonna LA; De Sanctis GT; Ingenito EP; Perrella MA
FASEB J; 2004 Aug; 18(11):1276-8. PubMed ID: 15208261
[TBL] [Abstract][Full Text] [Related]
7. Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes.
de Vera ME; Kim YM; Wong HR; Wang Q; Billiar TR; Geller DA
Hepatology; 1996 Nov; 24(5):1238-45. PubMed ID: 8903404
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.
Gilkeson GS; Mudgett JS; Seldin MF; Ruiz P; Alexander AA; Misukonis MA; Pisetsky DS; Weinberg JB
J Exp Med; 1997 Aug; 186(3):365-73. PubMed ID: 9236188
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.
Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC
Cancer Res; 2004 Oct; 64(19):6849-53. PubMed ID: 15466171
[TBL] [Abstract][Full Text] [Related]
10. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
11. A pathogenic role for JNK signaling in experimental anti-GBM glomerulonephritis.
Flanc RS; Ma FY; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
Kidney Int; 2007 Sep; 72(6):698-708. PubMed ID: 17597698
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease.
Kim JH; Ha IS; Hwang CI; Lee YJ; Kim J; Yang SH; Kim YS; Cao YA; Choi S; Park WY
Kidney Int; 2004 Nov; 66(5):1826-37. PubMed ID: 15496153
[TBL] [Abstract][Full Text] [Related]
13. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice.
Koglin J; Glysing-Jensen T; Mudgett JS; Russell ME
Am J Pathol; 1998 Nov; 153(5):1371-6. PubMed ID: 9811327
[TBL] [Abstract][Full Text] [Related]
14. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
15. Regulation of nitric oxide synthase 2 in rabbit corneal cells.
O'Brien WJ; Heimann T; Tsao LS; Seet BT; McFadden G; Taylor JL
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):713-9. PubMed ID: 11222532
[TBL] [Abstract][Full Text] [Related]
16. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation.
Isbel NM; Hill PA; Foti R; Mu W; Hurst LA; Stambe C; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Aug; 60(2):614-25. PubMed ID: 11473644
[TBL] [Abstract][Full Text] [Related]
17. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
Cui Z; Zhao MH
Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene.
Sewer MB; Barclay TB; Morgan ET
Mol Pharmacol; 1998 Aug; 54(2):273-9. PubMed ID: 9687568
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
